Literature DB >> 17492757

Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma.

Rahul A Parikh1, Jason S White, Xin Huang, David W Schoppy, Bora E Baysal, Rajasekaran Baskaran, Christopher J Bakkenist, William S Saunders, Lih-Ching Hsu, Marjorie Romkes, Susanne M Gollin.   

Abstract

About 45% of head and neck squamous cell carcinomas (HNSCC) are characterized by amplification of chromosomal band 11q13. This amplification occurs by a breakage-fusion-bridge (BFB) cycle mechanism. The first step in the BFB cycle involves breakage and loss of distal 11q, from FRA11F (11q14.2) to 11qter. Consequently, numerous genes, including three critical genes involved in the DNA damage response pathway, MRE11A, ATM, and H2AFX are lost in the step preceding 11q13 amplification. We hypothesized that this partial loss of genes on distal 11q may lead to a diminished DNA damage response in HNSCC. Characterization of HNSCC using fluorescence in situ hybridization (FISH) revealed concurrent partial loss of MRE11A, ATM, and H2AFX in all four cell lines with 11q13 amplification and in four of seven cell lines without 11q13 amplification. Quantitative microsatellite analysis and loss of heterozygosity studies confirmed the distal 11q loss. FISH evaluation of a small series of HNSCC, ovarian, and breast cancers confirmed the presence of 11q loss in at least 60% of these tumors. All cell lines with distal 11q loss exhibited a diminished DNA damage response, as measured by a decrease in the size and number of gamma-H2AX foci and increased chromosomal instability following treatment with ionizing radiation. In conclusion, loss of distal 11q results in a defective DNA damage response in HNSCC. Distal 11q loss was also unexpectedly associated with reduced sensitivity to ionizing radiation. Although the literature attributes the poor prognosis in HNSCC to 11q13 gene amplification, our results suggest that distal 11q deletions may be an equally significant factor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17492757     DOI: 10.1002/gcc.20462

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  36 in total

1.  Overexpression of KLF13 and FGFR3 in oral cancer cells.

Authors:  B J Henson; S M Gollin
Journal:  Cytogenet Genome Res       Date:  2010-06-02       Impact factor: 1.636

2.  Chromosomal changes characterize head and neck cancer with poor prognosis.

Authors:  Verena L Bauer; Herbert Braselmann; Michael Henke; Dominik Mattern; Axel Walch; Kristian Unger; Michael Baudis; Silke Lassmann; Reinhard Huber; Johannes Wienberg; Martin Werner; Horst F Zitzelsberger
Journal:  J Mol Med (Berl)       Date:  2008-09-23       Impact factor: 4.599

Review 3.  Histone variants: emerging players in cancer biology.

Authors:  Chiara Vardabasso; Dan Hasson; Kajan Ratnakumar; Chi-Yeh Chung; Luis F Duarte; Emily Bernstein
Journal:  Cell Mol Life Sci       Date:  2013-05-08       Impact factor: 9.261

4.  Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer.

Authors:  Ling Wang; Adam J Mosel; Gregory G Oakley; Aimin Peng
Journal:  Mol Cancer Ther       Date:  2012-09-12       Impact factor: 6.261

5.  Genetic gains and losses in oral squamous cell carcinoma: impact on clinical management.

Authors:  Ilda Patrícia Ribeiro; Francisco Marques; Francisco Caramelo; João Pereira; Miguel Patrício; Hugo Prazeres; José Ferrão; Maria José Julião; Miguel Castelo-Branco; Joana Barbosa de Melo; Isabel Poiares Baptista; Isabel Marques Carreira
Journal:  Cell Oncol (Dordr)       Date:  2013-12-19       Impact factor: 6.730

6.  Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.

Authors:  Madhav Sankunny; Rahul A Parikh; Dale W Lewis; William E Gooding; William S Saunders; Susanne M Gollin
Journal:  Genes Chromosomes Cancer       Date:  2013-11-25       Impact factor: 5.006

7.  Proteomic dissection of cell type-specific H2AX-interacting protein complex associated with hepatocellular carcinoma.

Authors:  Xiaoli Yang; Peng Zou; Jun Yao; Dong Yun; Huimin Bao; Ruyun Du; Jing Long; Xian Chen
Journal:  J Proteome Res       Date:  2010-03-05       Impact factor: 4.466

8.  ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines.

Authors:  C Ayoub; C Wasylyk; Y Li; E Thomas; L Marisa; A Robé; M Roux; J Abecassis; A de Reyniès; B Wasylyk
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

9.  H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy.

Authors:  Monika Podhorecka; Andrzej Skladanowski; Przemyslaw Bozko
Journal:  J Nucleic Acids       Date:  2010-08-03

Review 10.  H2AX: functional roles and potential applications.

Authors:  Jennifer S Dickey; Christophe E Redon; Asako J Nakamura; Brandon J Baird; Olga A Sedelnikova; William M Bonner
Journal:  Chromosoma       Date:  2009-08-26       Impact factor: 4.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.